Y. J. Lee

发表

Pharmacokinetic comparison of controlled-release and immediate-release oral formulations of simvastatin in healthy Korean subjects: a randomized, open-label, parallel-group, single- and multiple-dose study.

L. A. Lim, Kyungsoo Park, S. Jang, 2010, Clinical therapeutics.

Effect of HMGCR Variant Alleles on Low‐Density Lipoprotein Cholesterol—Lowering Response to Atorvastatin in Healthy Korean Subjects

S. Cho, L. A. Lim, Jae-Yong Chung, 2012, Journal of clinical pharmacology.

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

Tae Won Kim, J. Roh, H. Chung, 2012, Investigational New Drugs.

A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects

Y. J. Lee, J. Kang, Donghoon Shin, 2016, British journal of clinical pharmacology.

Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose study.

J. Choi, L. A. Lim, Jae-Yong Chung, 2011, Clinical therapeutics.

A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.

K. Kwon, Kyungsoo Park, Y. J. Lee, 2007, Clinical therapeutics.

Effect of CYP2B6 Genotype on the Pharmacokinetics of Sibutramine and Active Metabolites in Healthy Subjects

Jae-Yong Chung, Kyungsoo Park, S. Jang, 2011, Journal of clinical pharmacology.

A phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers

Y. J. Lee, Donghoon Shin, Minjeong Park, 2020, Cancer Chemotherapy and Pharmacology.

Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects.

Kyungsoo Park, Kyungsoo Park, S. Jang, 2007, British journal of clinical pharmacology.

The Safety and the Pharmacokinetics and Pharmacodynamics of a Pegylated Interferon Alpha-2a Formulation, Dong-A's DA-3021

L. A. Lim, Kyungsoo Park, S. Jang, 2010 .

A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects.

X. Pivot, G. Golor, E. Curtit, 2016, Clinical therapeutics.

CYP3A5*3 genotype associated with intrasubject pharmacokinetic variation toward tacrolimus in bioequivalence study

L. A. Lim, S. Jang, Y. J. Lee, 2010 .

Effects of a Medication Management Program for Cancer Patients Receiving Oral Chemotherapy

Y. J. Lee, Sue Kim, S. Han, 2018 .